GRS News

The National Institute for Health and Care Research (NIHR) Invention for Innovation (i4i) Programme is now accepting applications from researchers and organisations across the UK, including Scotland, Wales, and Northern Ireland. This expansion, effective since Autumn 2023, opens new opportunities for innovators in medical devices, in vitro diagnostics, and digital health technologies to secure funding for projects addressing existing or emerging health and social care needs.

i4i Funding Streams:

1. Product Development Awards (PDA): Support for collaborative research and development of medical devices, in vitro diagnostic devices, and high-impact patient-focused digital health technologies. Projects should have demonstrated proof-of-concept and a clear pathway towards adoption and commercialisation. There is no upper funding limit, but costs must be fully justified. Projects can last up to 36 months.
2. Connect: Aimed at small-to-medium-sized enterprises (SMEs) developing medical devices, in vitro diagnostics, and digital health technologies. This stream helps SMEs reach the next stage in the development pathway, making them more attractive for further funding or commercial investment. Funding ranges from £50,000 to £150,000 for projects lasting 6 to 12 months.
3. FAST (Funding At the Speed of Translation): Designed for innovators needing a small amount of funding to answer a specific question or fund a single piece of activity to advance healthcare technologies and interventions for increased patient benefit. Projects must have demonstrated experimental proof of concept as a minimum. Funding ranges from £50,000 to £100,000 for projects lasting 6 to 12 months.

GRS Support for Applicants:

At Global Regulatory Services (GRS), we understand the complexities involved in bringing innovative health technologies to market. Our award-winning consultancy offers a holistic approach to regulatory and quality compliance requirements within the life sciences industry.

Many of our clients have successfully secured funding through programmes like i4i, thanks to our expertise in navigating the regulatory landscape. We know precisely how to enhance your application from a regulatory perspective, ensuring it meets all necessary compliance standards.

Our Key Services Include:

• Regulatory Strategy Development: Crafting tailored strategies to meet specific project needs.
• Quality Compliance Support: Ensuring adherence to international quality standards throughout the product development lifecycle.
• Regulatory Submission Management: Guiding you through preparing and submitting regulatory documents to relevant authorities.
• Post-Market Surveillance: Assisting in monitoring product performance and compliance after market entry.

By partnering with GRS, you can focus on innovation while we handle the regulatory complexities, increasing your chances of securing i4i funding and successfully bringing your product to market.

Contact Our Experts:

To learn more about how GRS can support your i4i funding application and beyond, reach out to our team of experts today. Visit our website at https://globalregulatoryservices.com/ or email us at grs@globalregulatoryservices.com

Let GRS be your trusted partner in navigating the regulatory landscape, ensuring your innovative health solutions reach those who need them most.

To help potential applicants navigate the i4i Connect Call 9, NIHR is hosting a webinar on 11th February 2025 at 10 AM, providing an overview of the funding process and key requirements. The competition officially launches on 18th February 2025, with Stage 1 applications due by 18th March 2025 (1 PM). Shortlisted applicants will be invited to Stage 2, with the final submission deadline on 19th May 2025 (1 PM). If you're considering applying, now is the time to prepare. Register for the webinar here and stay ahead of the deadlines.